Neonatal abstinence syndrome ati template

Neonatal abstinence syndrome (NAS) is a treatable condition that newborns may experience as a result of prenatal exposure to certain substances, most often opioids. Neonatal opioid withdrawal syndrome (NOWS) is a related term that refers to the symptoms that infants may experience as a result of exposure to opioids specifically. Symptoms of NAS and NOWS may include severe irritability, difficulty feeding, respiratory problems, and seizures. Infants with NAS and NOWS are treated through non-pharmacological methods (such as rooming-in with mothers after birth, breastfeeding, swaddling, skin-to-skin time, and minimizing stimuli in the environment), as well as pharmacologic methods (medication) when warranted. Prior to birth, engaging pregnant women with opioid and other substance use disorders in substance use treatment and other services as a component of prenatal care can also mitigate or prevent negative birth outcomes associated with NAS and NOWS.

• Expand All | Collapse All

  • Substance Abuse and Mental Health Services Administration, 2018

    This clinical guide provides comprehensive, national guidance for optimal management of pregnant and parenting women with opioid use disorder and their infants. The clinical guide helps healthcare professionals and patients determine the most clinically appropriate action for a particular situation and informs individualized treatment decisions.

    Visit Website Clinical Guidance for Treating Pregnant and Parenting Women With Opioid Use Disorder and Their Infants

  • 
    (PDF 451 KB)

    Health Resources and Services Administration, 2018

    This resource for Maternal, Infant, and Early Childhood Home Visiting (MIECHV) awardees provides essential information about the opioid epidemic, opioid use disorder (OUD), and neonatal abstinence syndrome (NAS). It includes relevant research; offers strategies for MIECHV awardees and their state partners in early childhood, public health, and substance misuse and mental health treatment; and highlights promising efforts underway in Maine, Colorado, West Virginia, and Massachusetts.

    Visit Website HRSA’s Home Visiting Program: Supporting Families Impacted by Opioid Use and Neonatal Abstinence Syndrome

  • 
    (PDF 321 KB)

    California Healthcare Foundation, 2019

    This infographic compares the standard of care with emerging models for treating babies born with neonatal abstinence syndrome (NAS). This infographic can be used in presentations or other materials to build awareness for new models of care that are showing very promising results – both in terms of health outcomes for babies and in terms of cost-effectiveness.

    View Document HRSA’s Home Visiting Program: Supporting Families Impacted by Opioid Use and Neonatal Abstinence Syndrome

  • 
    (PDF 979 KB)

    Association of State and Territorial Health Officials, 2017

    This document provides a framework to aid in structuring stakeholder discussions at the state level to better understand how collective efforts can prevent in-utero opioid exposure and impact the incidence of NAS.

    View Document The Neonatal Abstinence Syndrome Framework

  • 
    (PDF 1.8 MB)

    Association of State and Territorial Health Officials, 2015

    This resource provides case examples and a suggested framework for states to consider when planning efforts aimed at addressing the NAS epidemic.

    View Document How State Health Departments Can Use the Spectrum of Prevention to Address Neonatal Abstinence Syndrome

  • 
    (PDF 548 KB)

    National Association of State Alcohol and Drug Abuse Directors, 2015

    This factsheet offers an overview of NAS, promising practices, and grant initiatives that address serving infants with NAS and their families.

    View Document Neonatal Abstinence Syndrome Factsheet

• • 

    This live webinar hosted by The National Center on Substance Abuse and Child Welfare (NCSACW) features Dr. Matthew Grossman who, together with his colleagues at Yale University, pioneered several changes in the care of infants with neonatal abstinence syndrome to reduce infants’ lengths of stay in the hospital. They transitioned from their usual practice to a focus on the “tasks for infants” of managing eating, sleeping, and consoling. Dr. Grossman shares the approach developed at Yale and the results.

    Presenter(s):

    • • Matthew Grossman, M.D., Associate Professor of Pediatrics (Hospital Medicine); Vice Chair for Quality, Department of Pediatrics; Quality and Safety Officer, Yale-New Haven Children’s Hospital

    Date: July 9, 2020

    Watch Video A Mother Centered Approach to Treat Neonatal Abstinence Syndrome

  • 

    This live webinar hosted by the National Center on Substance Abuse and Child Welfare (NCSACW) alongside Dr. Maya Balakrishnan discusses Tampa General Hospital’s Neonatal Intensive Care Unit (NICU) culture and practice changes in working with infants with prenatal substance exposure, their families, and their collaborative partnership with Florida’s Department of Health. This webinar provides an overview of neonatal abstinence syndrome, Florida Perinatal Quality Collaborative (FPQC), and practice changes and provider trainings in the NICU.

    Presenter(s):

    • • PresentersKen DeCerchio, M.S.W., CAP—Program Director, NCSACW
      • PresentersMaya Balakrishnan, M.D., CSSBB—Associate Professor of Pediatrics, University of South Florida (USF); Director of Quality and Safety, USF Graduate Medical Education (GME); Associate Director of Clinical and Quality Management, FPQC

    Date: February 2020

    Watch Video Infants With Prenatal Substance Exposure: Yale New Haven Children’s Hospital’s Approach

  • 

    National Center on Substance Abuse and Child Welfare, 2018

    This webinar provides an overview the Yale New Haven Children’s Hospital initiative to improve the quality of care of infants with neonatal abstinence syndrome. Dr. Matthew Grossman highlights research findings, including the methods and results of the hospital study published in Pediatrics. The interventions include non-pharmacologic therapies and a simplified approach to assessment for infants exposed to methadone in utero.

    Watch Video Infants With Prenatal Substance Exposure: Yale New Haven Children’s Hospital’s Approach

  • 

    Association of State and Territorial Health Officials, 2019

    This webinar from the OMNI Learning Community highlights neonatal abstinence syndrome (NAS) and how using a statewide, multidisciplinary approach to NAS can address several levels of intervention.

    Watch Video Opioid Use Disorder, Maternal Outcome, Neonatal Abstinence Syndrome Initiative Learning Community

  • 

    California Health Care Foundation, 2018

    Matthew Grossman, M.D., of Yale University explains a family-centered approach to care that lowered hospital stays from 30 to 5 days for babies born with neonatal abstinence syndrome.

    Watch Video Reconsidering the Standard Approach to Neonatal Abstinence Syndrome

  • 

    Texas Department of State Health Services, 2014

    This video showcases professionals and mothers demonstrating techniques to help soothe withdrawal symptoms associated with neonatal abstinence syndrome and describes the important role that birth mothers play in their child’s recovery.

    Watch Video Stronger Together: NAS Soothing Techniques for Mommies and Babies

• • 
    (PDF 1.25 MB)

    Florida Perinatal Quality Collaborative, 2019

    This tool kit is intended to provide guidance to hospitals and neonatal providers in the development of individualized policies and protocols related to NAS. It is not to be construed as a standard of care; rather, it is a collection of resources that may be adapted by local institutions in order to develop standardized protocols for NAS. The tool kit will be updated as additional resources become available.

    View Document Florida Neonatal Abstinence Syndrome (NAS) Tool Kit: A Quality Improvement Initiative

  • 
    (DOCX 16 KB)

    Colorado Hospital Substance Exposed Newborns Collaborative, 2018

    The CHoSEN Collaborative is an effort to increase consistency in implementation of best practice in the identification of and response to newborns prenatally exposed to substances throughout the Rocky Mountain region. This resource provides hospitals with a list of steps as they implement the Eat, Sleep, Console method for infants with NAS.

    View Document Hospital Checklist for Adoption of the Eat, Sleep, Console NAS Assessment Items

  • 
    (DOCX 19 KB)

    Colorado Hospital Substance Exposed Newborns Collaborative, 2018

    This resource from the CHoSEN Collaborative provides healthcare professionals with strategies as they standardize non-pharmacologic interventions for infants with neonatal abstinence syndrome.

    View Document Non-pharmacologic Care for Substance Exposed Newborns

  • 
    (PDF 427 KB)

    National Center on Substance Abuse and Child Welfare, 2017

    This report highlights the efforts of five states participating in NCSACW’s Substance-Exposed In-Depth Technical Assistance (SEI-IDTA) initiative. The initiative focused on strengthening collaboration and linkages among child welfare, mental health and substance use disorder treatment, public health and medical communities, home visiting providers, and other key stakeholders to improve outcomes for infants with prenatal exposure, their mothers, and families.

    View Document Substance-Exposed Infants: A Report on Progress in Practice and Policy Development in States Participating in a Program of In-Depth Technical Assistance, September 2014 to September 2016

  • 
    (PDF 5.1 MB)

    Ohio Perinatal Quality Collaborative, 2014

    This guide is for parents and caregivers of infants with NAS. It provides an overview of NAS and explains its symptoms, treatment and caregiving strategies, and what to expect when caring for an infant with NAS.

    View Document Neonatal Abstinence Syndrome: A Guide for Families

• • 
    (PDF 158 KB)

    American Academy of Pediatrics, 2020

    The infographic outlines the fundamental opportunities presented to pediatricians when working with families with a history of opioid use. Screening and early identification of prenatal opioid use, along with appropriate referrals for both mothers and infants, are key to sustaining the mother-infant dyad. Pediatricians can build a supportive environment and advance an empathetic strength-based approach to engage mothers with opioid use disorder (OUD) into care and treatment.

    View Document Partner With Mothers To Seek and Support Recovery Post Prenatal Opioid Exposure

  • 
    (PDF 185 KB)

    American Academy of Pediatrics, 2020

    The factsheet captures the core questions asked by pediatricians with respect to the Plans of Safe Care provisions outlined in the Child Abuse Prevention and Treatment Act (CAPTA). Supportive measures taken toward pregnant women who have a history of prenatal substance use are in the best interest of the mother-infant dyad. Pediatricians and other providers working with families affected by prenatal opioid use can advance an individualized approach to their care within the context of a family-centered system of services.

    View Document Substance Use During Pregnancy and Plans of Safe Care (POSC): Implications for Pediatricians, Mothers, and Infants

  • 
    (PNG 182 KB)

    National Perinatal Association

    This infographic provides key steps in caring for a baby with neonatal abstinence syndrome.

    View Image How To Care for a Baby With NAS

How do you test for neonatal abstinence syndrome?

Which signs are associated with neonatal abstinence syndrome?

What is NAS scoring in newborns?

What care is appropriate for the infant with neonatal abstinence syndrome?